Borderline personality disorder does not have a first choice pharmacological treatment. We studied 20 borderline inpatients in a double-blind parallel placebo-controlled trial with carbamazepine for a mean of 30.9 days. No significant positive effects of the drug were found.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0924-977x(94)90296-8 | DOI Listing |
Publication Analysis
Top Keywords
trial carbamazepine
8
borderline personality
8
personality disorder
8
carbamazepine borderline
4
disorder borderline
4
disorder choice
4
choice pharmacological
4
pharmacological treatment
4
treatment studied
4
studied borderline
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!